Goldman Sachs Group Inc Horizon Therapeutics Public LTD CO Put Options Transaction History

Goldman Sachs Group Inc

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 May 14, 2024	BUY	$96.34 - $112.38 $18.7 Million - $21.9 Million	194,600 Added 3603.7%	200,000 $20.6 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $18.7 Million - $21.9 Million	194,600 Added 3603.7%	200,000 $20.6 Million
Q4 2022 May 14, 2024	BUY	$62.39 - $113.8 $336,906 - $614,520	5,400 New	5,400 $614,000
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $336,906 - $614,520	5,400 New	5,400 $614,000
Q3 2021 Nov 10, 2021	BUY	$91.91 - $110.37 $459,550 - $551,850	5,000 New	5,000 $548,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.